| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |